Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 10/20 | 0.81 |
| ▸ | PPARG | P37231 | 9/20 | 0.81 |
| ▸ | PPARA | Q07869 | 9/20 | 0.81 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.58 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.58 |
| ▸ | LTB4R | Q15722 | 6/20 | 0.40 |
| ▸ | LTB4R2 | Q9NPC1 | 3/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.39 |
| ▸ | CYSLTR2 | Q9NS75 | 3/20 | 0.38 |
| ▸ | CYSLTR1 | Q9Y271 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6933762 | 0.92 | PPARG (0.69) | PPARDPPARGPPARANR1H2NR1H3 | |
| SCHEMBL6939266 | 0.92 | PPARD (0.79) | PPARDPPARGPPARANR1H2NR1H3 | |
| SCHEMBL6932940 | 0.90 | PPARD (0.82) | PPARDPPARGPPARANR1H2NR1H3 | |
| SCHEMBL6933714 | 0.90 | PPARD (0.82) | PPARDPPARGPPARANR1H2NR1H3 | |
| SCHEMBL6937919 | 0.90 | PPARD (0.69) | PPARDPPARGPPARANR1H2NR1H3 | |
| SCHEMBL6933330 | 0.90 | PPARG (1.00) | PPARDPPARGPPARANR1H2NR1H3 | |
| SCHEMBL6933139 | 0.85 | PPARG (0.66) | PPARDPPARGPPARANR1H2NR1H3 | |
| SCHEMBL6936461 | 0.85 | PPARG (0.59) | PPARDPPARGPPARANR1H2NR1H3 | |
| SCHEMBL6936760 | 0.83 | PPARG (0.88) | PPARDPPARGPPARANR1H2NR1H3 | |
| SCHEMBL10892351 | 0.83 | PPARG (1.00) | PPARDPPARGPPARANR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888278-B1 | ANTIDIABETIC AGENTS | MERCK & CO INC (US) | 2003-07-23 | — | — | EP | claimed |
| EP-0888278-A4 | ANTIDIABETIC AGENTS | MERCK & CO INC (US) | 1999-06-30 | — | — | EP | claimed |
| EP-0888278-A1 | ANTIDIABETIC AGENTS | Merck & Co., Inc. (US) | 1999-01-07 | — | — | EP | claimed |
| WO-1997028115-A1 | ANTIDIABETIC AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | claimed |
| EP-0888278-B1 | ANTIDIABETIC AGENTS | MERCK & CO INC (US) | 2003-07-23 | — | — | EP | disclosed |
| EP-0888278-A4 | ANTIDIABETIC AGENTS | MERCK & CO INC (US) | 1999-06-30 | — | — | EP | disclosed |
| EP-0888278-A1 | ANTIDIABETIC AGENTS | Merck & Co., Inc. (US) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997028115-A1 | ANTIDIABETIC AGENTS | MERCK & CO., INC. (US) | 1997-08-07 | — | — | WO | disclosed |